On Wednesday, East West Bancorp, Inc. (NASDAQ:EWBC)’s shares inclined 0.38% to $44.99.
East West Bancorp (EWBC) will release second quarter 2015 financial results after the market closes on Wednesday, July 15, 2015.
Conference Call Information
Administration will talk about second quarter 2015 financial results with the public on Thursday, July 16, 2015 at 8:30 A.M. PT/ 11:30 A.M. ET via conference call. The public and investment community are invited to listen as administration talk about second quarter results and operating developments.
East West Bancorp, Inc. operates as the bank holding company for East West Bank that provides a range of personal and commercial banking services to small and medium-sized businesses, business executives, professionals, and other individuals. The company operates in three segments: Retail Banking, Commercial Banking, and Other. It offers various deposit products comprising personal and business checking and savings accounts, time deposits and individual retirement accounts, travelers checks, safe deposit boxes, and MasterCard and Visa merchant deposit services.
New York Mortgage Trust Inc (NASDAQ:NYMT)’s shares gained 1.94% to $7.62.
New York Mortgage Trust Inc (NYMT) declared that its Board of Directors declared a regular quarterly cash dividend of $0.27 per share on shares of its common stock for the quarter ending June 30, 2015. The dividend will be payable on July 27, 2015 to common stockholders of record as of June 29, 2015.
New York Mortgage Trust, Inc., a real estate investment trust (REIT), engages in acquiring, investing in, financing, and managing mortgage-related and financial assets in the United States. It primarily invests in residential mortgage-backed securities comprising adjustable-rate, hybrid adjustable-rate, fixed-rate, interest only and inverse interest only, and principal only mortgage-backed securities; multifamily commercial mortgage-backed securities; and residential mortgage loans, counting loans sourced from distressed markets.
At the end of Wednesday’s trade, SunPower Corporation (NASDAQ:SPWR)‘s shares dipped -1.80% to $27.90.
A joint venture between two solar PV makers has set its terms for an initial public offering (IPO) that is predictable to price next week. 8point3 Energy Partners is a solar energy yieldco formed by SunPower Corp. (NASDAQ: SPWR) and First Solar Inc. (NASDAQ: FSLR).
The new company’s initial portfolio of assets comprises 262 megawatts of generation from four First Solar-owned plants and 163 megawatts of generation from SunPower-owned plants. The partners have also award rights of first offer to 8point3 on another 1,143 megawatts of generation.
8point3 is organized as a limited partnership and will be treated as a corporation for U.S. federal income tax purposes. Distributions to the holders of the company’s shares will be taxable as ordinary dividend income to the extent of 8point3’s current and accumulated earnings and profits as computed for U.S. federal income tax purposes. The company anticipates to pay an annual distribution of $0.8388 per share initially, and it is targeting its annual distribution growth rate at 12% to 15% per share for the three years following the IPO.
SunPower Corporation designs, manufactures, and delivers solar systems to residential, commercial, and utility-scale power plant customers worldwide. The company offers solar power components, counting panels, balance of system components, and inverters. It also offers rooftop and ground-mounted solar power systems, counting residential systems, commercial roof and ground mounted systems, utility and power plant systems, and utility-scale photovoltaic power plants.
Hologic, Inc. (NASDAQ:HOLX), ended its Wednesday’s trading session with 0.18% gain, and closed at $38.13.
Hologic, Inc. (HOLX) declared recently that it has notified holders of the 2.00% Convertible Exchange Senior Notes due 2037 (CUSIP No. 436440 AB7) issued November 23, 2010, and Wilmington Trust Company, the trustee, paying agent and conversion agent for the notes, that holders are eligible to convert the notes. This conversion right is subject to the terms of the base indenture governing the notes dated as of December 10, 2007, as supplemented by the second supplemental indenture dated as of November 23, 2010 (collectively, the indenture).
The conversion right has been triggered because the closing price of the Company’s common stock exceeded about $29.94, which is 130% of the conversion price for the notes, for at least 20 of the 30 successive trading days ending on June 30, 2015. As a result, the notes are convertible until September 30, 2015 subject to the terms, conditions and adjustments in the indenture and the notes. The notes may continue to be convertible after September 30, 2015 if one or more conditions specified in the indenture are satisfied during future measurement periods.
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States and internationally. The company operates in four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment provides Aptima family of assays, target capture/nucleic acid extraction technology, transcription-mediated amplification technology, hybridization protection and dual kinetic assays, instrumentation, Invader chemistry platform, ThinPrep system, fetal fibronectin tests, Procleix family of assays, and virology and infectious disease products.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
